D630045J12Rik Activators
D630045J12Rik, a gene located in the photoreceptor connecting cilium, plays a crucial role in retinitis pigmentosa 86 and is expressed in various tissues, including the retina and central nervous system. To explore potential regulators of D630045J12Rik, we identified chemical activators that could up-regulate or stimulate its function. These activators act through diverse pathways, impacting processes such as cAMP signaling, retinoid pathways, Wnt signaling, and chromatin remodeling. Forskolin and rolipram, both cAMP modulators, may enhance D630045J12Rik activation by influencing the cAMP-dependent pathway, contributing to its role in retinitis pigmentosa 86. Retinoic acid, a retinoid pathway modulator, may stimulate D630045J12Rik by affecting retinoid signaling, emphasizing its involvement in photoreceptor development.
Lithium chloride and CHIR99021, inhibitors of GSK-3, may promote D630045J12Rik function through Wnt signaling, suggesting a potential regulatory mechanism in the photoreceptor connecting cilium. Trichostatin A, an HDAC inhibitor, and LY294002, a PI3K inhibitor, could impact D630045J12Rik by influencing chromatin remodeling and PI3K/AKT signaling, respectively. These diverse pathways converge to regulate D630045J12Rik, emphasizing its multifaceted involvement in cellular processes. Understanding these chemical activators provides insights into the complex regulatory network governing D630045J12Rik and its role in retinitis pigmentosa 86, contributing to our broader understanding of retinal function and potential avenues for related disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a vitamin A derivative, may indirectly activate D630045J12Rik. Through its involvement in retinoid signaling, retinoic acid influences photoreceptor development and function. Retinoic acid's impact on retinoid pathways could contribute to the enhanced activation of D630045J12Rik in the photoreceptor connecting cilium, promoting its role in retinitis pigmentosa 86 and related processes in the retina. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride, a GSK-3 inhibitor, may indirectly activate D630045J12Rik. Inhibiting GSK-3 with lithium chloride influences the Wnt signaling pathway, potentially impacting D630045J12Rik in the photoreceptor connecting cilium. Lithium chloride's modulation of Wnt signaling could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina and central nervous system. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a phosphodiesterase inhibitor, may indirectly activate D630045J12Rik. By increasing cAMP levels through phosphodiesterase inhibition, rolipram stimulates the cAMP-dependent pathway, potentially influencing D630045J12Rik in the photoreceptor connecting cilium. Rolipram's impact on cAMP signaling could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542, a TGF-β receptor inhibitor, may indirectly activate D630045J12Rik. Inhibiting TGF-β signaling with SB431542 influences cellular processes, potentially impacting D630045J12Rik in the photoreceptor connecting cilium. SB431542's modulation of TGF-β signaling could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina and central nervous system. | ||||||
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $312.00 | 1 | |
BMS-345541, an IKK inhibitor, may indirectly activate D630045J12Rik. Inhibiting IKK influences the NF-κB signaling pathway, potentially impacting D630045J12Rik in the photoreceptor connecting cilium. BMS-345541's modulation of NF-κB signaling could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina and central nervous system. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, may indirectly activate D630045J12Rik. Inhibiting PI3K affects the PI3K/AKT signaling pathway, potentially impacting D630045J12Rik in the photoreceptor connecting cilium. LY294002's modulation of PI3K/AKT signaling could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina and central nervous system. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an HDAC inhibitor, may indirectly activate D630045J12Rik. Inhibiting HDAC influences chromatin remodeling, potentially impacting D630045J12Rik in the photoreceptor connecting cilium. Trichostatin A's modulation of HDAC activity could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina and central nervous system. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y27632, a ROCK inhibitor, may indirectly activate D630045J12Rik. Inhibiting ROCK influences actin cytoskeleton dynamics, potentially impacting D630045J12Rik in the photoreceptor connecting cilium. Y27632's modulation of actin cytoskeleton dynamics could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina and central nervous system. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI (CHIR99021), a GSK-3 inhibitor, may indirectly activate D630045J12Rik. Inhibiting GSK-3 influences the Wnt signaling pathway, potentially impacting D630045J12Rik in the photoreceptor connecting cilium. CHIR99021's modulation of Wnt signaling could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina and central nervous system. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK inhibitor, may indirectly activate D630045J12Rik. Inhibiting MEK affects the MAPK/ERK signaling pathway, potentially impacting D630045J12Rik in the photoreceptor connecting cilium. U0126's modulation of MAPK/ERK signaling could contribute to the enhanced activation of D630045J12Rik, promoting its function in retinitis pigmentosa 86 and related processes in the retina and central nervous system. | ||||||